NCT03176121View on ClinicalTrials.gov

Study Evaluating Safety and Tolerability of Oxycodone in Patients With Moderate to Severe Cancer Pain

PHASE4CompletedINTERVENTIONAL
Enrollment

73

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions
CancerPain
Interventions
DRUG

Oxycodone

Patients will take either CR oxycodone or IR oxycodone or both for initial dose and used it to titrate his/her background dose.

Trial Locations (10)

111

Shin Kong Wu Ho-Su Memorial Hospital, Taipei

114

Tri-Service General Hospital, Taipei

204

Chang Gung Memorial Hospital, Keelung branch, Keelung

333

Chang Gung Memorial Hospital, LinKou branch, Taoyuan

500

Changhua Christian Hospital, Chang-hua

10449

MacKay Memorial Hospital, Taipei

40447

China Medical University Hospital, Taichung

83301

Chang Gung Memorial Hospital, Kaohsiung branch, Kaohsiung City

Unknown

Chang Gung Memorial Hospital, Chiayi branch, Chiayi City

Taichung Veterans General Hospital, Taichung

All Listed Sponsors
lead

Taiwan Mundipharma Pharmaceuticals Ltd.

INDUSTRY

NCT03176121 - Study Evaluating Safety and Tolerability of Oxycodone in Patients With Moderate to Severe Cancer Pain | Biotech Hunter | Biotech Hunter